Journal Guides6 min readUpdated Mar 21, 2026

Lancet Oncology Acceptance Rate

The Lancet Oncology acceptance rate is about 10%. Use it as a selectivity signal, then sanity-check scope, editorial fit, and submission timing.

By Associate Professor, Clinical Medicine & Public Health•

Associate Professor, Clinical Medicine & Public Health

Author context

Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.

Journal evaluation

Want the full picture on The Lancet Oncology?

See scope, selectivity, submission context, and what editors actually want before you decide whether The Lancet Oncology is realistic.

Open The Lancet Oncology GuideAnthropic Privacy Partner. Zero-retention manuscript processing.Run Free Readiness Scan

Lancet Oncology accepts approximately 8-10% of submissions. Desk rejection accounts for 70-80%, typically within 1-2 weeks. These numbers are comparable to the parent Lancet and reflect the same editorial philosophy: the evidence must be strong enough to change clinical practice.

Quick answer

Lancet Oncology's overall acceptance rate is roughly 8-10%. The desk is the main filter (70-80% rejected). Papers that reach peer review have an estimated 30-40% acceptance rate. The editorial test is whether the finding changes oncology practice globally, backed by evidence strong enough to survive in-house statistical scrutiny.

The numbers

Metric
Value
Overall acceptance rate
~8-10%
Estimated desk rejection rate
70-80%
Post-review acceptance rate
~30-40% (estimated)
Impact Factor (2024 JCR)
35.9
Publisher
Lancet Publishing Group

Where papers get filtered

The desk (70-80%)

Lancet Oncology's desk rejection is fast and focused. The editors ask: does this paper present clinical evidence that could change how oncologists treat patients globally? Papers filtered at the desk include:

  • Cancer biology without clinical endpoints
  • Phase I/II studies without clear practice implications
  • Regional studies without global relevance
  • Observational studies with limited causal inference

Peer review (remaining ~20-30%)

Papers that survive the desk face concurrent clinical and statistical review. The in-house statisticians (inherited from the Lancet system) add rigor that many journals don't match. Post-review rejections happen when:

  • Statistical limitations undermine the clinical conclusion
  • The practice-changing claim isn't supported by the evidence level
  • Reviewers identify design issues the authors didn't address

Should you submit?

Submit if:

  • the evidence could change oncology treatment guidelines
  • the trial design is randomized or the observational evidence is exceptionally strong
  • the finding matters to oncologists worldwide, not just in one healthcare system

Think twice if:

  • JCO (higher IF, broader scope) would be a more practical target
  • the paper is cancer biology (Cancer Cell, Nature Cancer are better homes)
  • the statistical design has known limitations

A free manuscript scan can help assess whether the evidence strength meets Lancet Oncology's threshold.

FAQ

What is the Lancet Oncology acceptance rate?

Approximately 8-10%. Most rejections happen at the desk (70-80%).

Is Lancet Oncology harder to get into than JCO?

Similar selectivity (~8-10% vs ~10%). JCO publishes more papers and has a broader scope. Lancet Oncology is specifically about global practice change.

References

Sources

  1. Clarivate Journal Citation Reports (released June 2025)
  2. Lancet Oncology information for authors

Reference library

Use the core publishing datasets alongside this guide

This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.

Open the reference library

Dataset / reference guide

Peer Review Timelines by Journal

Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.

Dataset / benchmark

Biomedical Journal Acceptance Rates

A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.

Reference table

Journal Submission Specs

A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.

Before you upload

Want the full picture on The Lancet Oncology?

Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.

These pages attract evaluation intent more than upload-ready intent.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Open The Lancet Oncology GuideRun Free Readiness Scan
Internal navigation

Where to go next

Start here

Same journal, next question

Supporting reads

Conversion step

Back to all articles
Open The Lancet Oncology Guide